Onconetix, Inc. (ONCO) financial statements and ratios from SEC XBRL: revenue $815371.00 (TTM), net margin -1721.0%, revenue growth -67.7% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $815371.00 |
| Net Margin | -1721.0% |
| Revenue Growth (YoY) | -67.7% |
| EPS Growth (YoY) | -22.8% |
| Price / Book | 0.19 |
| Price / Sales | 7.05 |
| Altman Z-Score | -9.70 (distress) |
| Sector P/E (Healthcare) | 21.7 |
ONCO overview · ONCO earnings · ONCO KPIs · ONCO investor relations · ONCO ownership · ONCO peers · ONCO filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.